The 2,3-benzobicyclo[3.3.1]non-2-ene scaffold is a bridged backbone of many bioactive natural products. The development of a concise tactic toward this architecture is of keen interest and highly challenging. Herein, we disclose a novel cascade protocol for realizing this target. This approach relies on a domino sequence of carbocation rearrangement and Ritter reaction of the taiwaniaquinoid scaffold derivatives. A process of dienone-phenol rearrangement was postulated to be involved. Several potentially useful compounds with this intricate bridged ring were obtained in good overall yields (59-83%, over 2 steps).
No takes yet. Share an insight, caveat, or question.
Sun et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: